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Abstract
This paper reports rational engineering of Trypanosoma rangeli sialidase to develop an effective enzyme for a potentially
important type of reactivity: production of sialylated prebiotic glycans. The Trypanosoma cruzi trans-sialidase and the
homologous T. rangeli sialidase has previously been used to investigate the structural requirements for trans-sialidase
activity. We observed that the T. cruzi trans-sialidase has a seven-amino-acid motif (197–203) at the border of the substrate
binding cleft. The motif differs substantially in chemical properties and substitution probability from the homologous
sialidase, and we hypothesised that this motif is important for trans-sialidase activity. The 197–203 motif is strongly
positively charged with a marked change in hydrogen bond donor capacity as compared to the sialidase. To investigate the
role of this motif, we expressed and characterised a T. rangeli sialidase mutant, Tr13. Conditions for efficient trans-sialylation
were determined, and Tr13’s acceptor specificity demonstrated promiscuity with respect to the acceptor molecule enabling
sialylation of glycans containing terminal galactose and glucose and even monomers of glucose and fucose. Sialic acid is
important in association with human milk oligosaccharides, and Tr13 was shown to sialylate a number of established and
potential prebiotics. Initial evaluation of prebiotic potential using pure cultures demonstrated, albeit not selectively, growth
of Bifidobacteria. Since the 197–203 motif stands out in the native trans-sialidase, is markedly different from the wild-type
sialidase compared to previous mutants, and is shown here to confer efficient and broad trans-sialidase activity, we suggest
that this motif can serve as a framework for future optimization of trans-sialylation towards prebiotic production.
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Introduction
For production of human milk oligosaccharides (HMOs), glycan
sialylation can be achieved chemically as well as enzymatically [1].
To achieve enzymatic synthesis, a trans-sialidase (TcTS) derived
from T. cruzi, the causative agent of Chagas disease, has previously
proven useful by transferring sialic acid from a donor to an
acceptor glycan [2]. However, for industrial production of food-
grade HMOs, it is a drawback that the enzyme constitutes an
important virulence factor within T. cruzi [3]. Redesigning mutants
of the non-pathogenic T. rangeli sialidase (TrSA) that possesses
relatively low trans-sialidase activity [4] provides an attractive
alternative for application in bioconversion processes. TrSA is
70% identical to TcTS and has the same overall tertiary structure.
Both enzymes have been extensively characterised by biochemical,
mutational and structural studies, and they share a common
double displacement mechanism with a tyrosine as the catalytic
nucleophile [5,6].
In TcTS, the acceptor binding site consists of Y119 and W312
which form stacking interactions with the acceptor sugar [7]. In
TrSA, W313 (corresponds to W312 in TcTS) is found in a
different conformation due to a Q284P substitution, while the
Y120 (corresponds to Y119 in TcTS) is replaced by serine [8]. In
addition to these differences in the acceptor binding site, a
conserved D97 hydrogen bonds differently to sialic acid in the two
enzymes, possibly due to the substitutions V96M and P98A.
Correction of both the acceptor-binding site (S120Y, G249Y, and
Q284P) and the sialic acid binding pocket (M96V, and A98P) is
required to confer trans-sialidase activity (1% of TcTS activity) to
TrSA, and the additional single mutations I37L (in this study
named Tr6) and G342A further increase activity to 10% of the
TcTS activity [9,4]. Kinetic data, however, indicate that the
mutants display a .25-fold lower affinity for lactose and .100-
fold higher kcat for the undesired, competing hydrolysis [4],
indicating ample room for further improvement.
In this study, we carried out a rational design of the T. rangeli
mutant sialidase Tr6 based on the identification of a major
difference (the motif constituted by amino acids 197–203) close to
the binding cleft. We hypothesised that this motif might affect the
trans-sialidase vs. hydrolase activity, notably due to the extremely
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unusual (and substitution-wise unlikely) +3 charge change in this
segment of the native trans-sialidase. Our production and
characterisation of a T. rangeli mutant sialidase (Tr13) from the
Tr6 parent incorporating this motif confirmed this hypothesis,
since a reduced hydrolytic activity was observed which promoted
overall trans-sialylation efficiency. Using a side-stream component
from the dairy industry, casein glycomacropeptide (cGMP), as
sialic acid donor for Tr13, we were able to sialylate a number of
established and potential prebiotic glycans, demonstrating a broad
acceptor specificity of Tr13.
Materials and Methods
Substrates
para-Nitrophenyl neuraminic acid (pNP-Neu5Ac) was pur-
chased from Sigma-Aldrich (Steinheim, Germany). 39-sialyllactose
and 69-sialyllactose were obtained from Carbosynth (Compton,
United Kingdom). The commercial casein glycomacropeptide
(cGMP) product LACPRODAN CGMP-20 with a sialic acid
content of about 9% (w/w) was supplied by Arla Foods (Viby,
Denmark), and low molecular weight impurities were removed by
filtration with a 5 kDa membrane. 4-methylumbelliferyl-b-D-
galactopyranoside (MU-Gal), b-lactose, lactulose, melibiose, malt-
ose, and fucose were purchased from Sigma-Aldrich (Steinheim,
Germany). Galactooligosacchardies (GOS) were purchased from
Gulio Gross (Trezzano, Italy). Iso-maltooligosaccharides (IMO)
were kindly provided by Taka Hayashi from Kyoto University,
RISH (Gokasho, Japan).
Rational mutant selection
Sialidase catalytic domains were identified using NCBI Con-
served Domain Search [10]. Pymol v1.3 (Schro¨dinger) was used to
identify amino acids within 14 A˚ of the sialic acid binding site,
based on the crystal structure with PDB code 1WCS, and was also
used for preparing the figures. The T. rangeli sialidase mutant Tr6
(see below) and trans-sialidases from T. cruzi (TcTS) (Uniprot ID
Q26966), Trypanosoma congolense (Uniprot ID G0WJG3) [11] and
Trypanosoma brucei (Uniprot ID Q57XJ2) [12] were aligned using
ClustalW [13]. Ranking of chemical difference between substitut-
ed amino acids in Tr6 vs. TcTS was done based on being first- or
second sphere relative to the substrate and based on the polar/
nonpolar and small/large distinction; such property-based selec-
tion turned out to correlate well with standard substitution
matrices (BLOSUM62), i.e. the most unlikely substitutions were
considered noteworthy. A comparison of loop structures in T. cruzi
and T. rangeli with and without a substrate analogue DANA (2, 3-
Dehydro-2-deoxy-N-acetylneuraminic acid) bound was made
using structures of TcTS (PDB codes 1MS1 and 1MS3) and
TrSA (PDB codes 1N1S and 1N1T). A 3D-model of Tr13 was
made using the Modeller software [14] with 1WCS as the
template.
DNA manipulations and strain construction
A gene encoding Tr6, T. rangeli sialidase mutant TrSA5mut (the
sequence was extracted from PDB file 1WCS) with an additional
mutation I37L [4], was codon-optimized for expression in Pichia
pastoris and synthesized by DNA2.0 (Menlo Park, CA, USA). The
synthesized gene was inserted in the P. pastoris expression vector
pPICZaC (Invitrogen) between the XhoI and XbaI restriction sites
generating a translational fusion to the a-factor signal sequence as
well as a C-terminal c-myc epitope and a 6xHis tag (Figure S1). The
plasmid was propagated in Escherichia coli NM522 grown at 37uC
with shaking in low salt LB medium (10 g/L tryptone, 5 g/L yeast
extract, and 5 g/L NaCl) supplemented with 25 mg/mL zeocin.
This vector, pPICZa-Tr6, was used as a template for introduction
of additional mutations by PCR using overlapping primers
(Table 1). The PCR products were inserted in pPICZaC between
the XhoI and XbaI sites. Constructs were sequenced to confirm the
mutations and to assure that no unwanted mutations had been
introduced by PCR. In the following, the mutants are denoted by
the amino acid change compared to the parent (e.g. Tr6 Q123R),
except for the multi-mutant denoted Tr13, in which amino acids
197–203 were changed from IADMGGR to VTNKKKQ. P.
pastoris X-33 was transformed with the constructs by electropora-
tion following the manufacturer’s instructions (Invitrogen).
Protein synthesis and purification
For small-scale protein synthesis, P. pastoris X-33 strains
harboring pPICZa with mutated genes were grown for three days
in 180 mL BMMY (10 g/L yeast extract, 20 g/L peptone,
100 mM potassium phosphate (pH 6), 13.4 g/L yeast nitrogen
base, 0.4 mg/L biotin and 0.5% methanol) shaking at 30uC.
Protein synthesis was induced every 24 hours by addition of
methanol to a final concentration of 0.5%. Cells were removed by
centrifugation for 5 min at 3000 g and the supernatant was
subsequently sterile filtered using a 0.2 mM Minisart filter
(Sartorius AG). The supernatant was concentrated about 100-fold
using Vivaspin20 concentrators with a 30 kDa cutoff (Sartorius
AG). The 6xHis-tagged protein was purified from concentrated
samples using Ni-sepharose (GE Healthcare) columns in accor-
dance with manufacturer’s instructions, followed by desalting on
PD-10 columns (GE Healthcare) using 20 mM sodium phosphate
buffer (pH 7.4), containing100 mM NaCl, and 10% glycerol. The
protein sample was finally concentrated to about 200 mL using a
Vivaspin0.5 concentrator with a 50 kDa cutoff (Sartorius AG).
For large-scale production, Tr6, Tr13, and Tr6 D363E were
produced in a 5 L Sartorius Biostat Aplus fermentor as described
previously [15]. The enzymes were purified by Cu2+ affinity
column chromatography as described previously [16]. Protein
concentrations were determined using the BCA protein assay
(Thermo Scientific) with bovine serum albumin as standard.
Sialidase activity assays
Sialidase activity was measured in a reaction containing 50 mM
phosphate-citrate buffer (pH 7), 0.75 mM pNP-NeuAc, and 3 mg/
mL sialidase enzyme. The reactions were initiated by addition of
substrate and were then followed spectrophotometrically at
410 nm at 30uC. pH 7 was chosen to enable detection of released
pNP in a continuous assay. Reaction rates were normalized as
percent of the activity of Tr6. For measurement of hydrolysis of
natural substrates, the assay was done with either 1 mM 39-
sialyllactose, 1 mM 69-sialyllactose, or 1 mM cGMP-bound sialic
acid in 50 mM phosphate-citrate buffer (pH 5) using 1 mg/mL
enzyme. Reactions were started by addition of enzyme and
stopped by adding H2SO4 to a final concentration of 45 mM.
Quantification of free sialic acid was done using a 2-thiobarbituric
acid assay [17] with the modification that butanol extraction was
substituted with mixing with dimethyl sulfoxide (DMSO) [18].
Trans–sialidase activity assay
Trans-sialidase activity was assayed as described previously [19]
but with several modifications. Reactions were done in 50 mM
phosphate-citrate (pH 6) at 30uC using 2.9 mg/mL enzyme. As
donor substrate, 1 mM cGMP-bound sialic acid was used, and
MU-Gal was used as acceptor. The low solubility in aqueous
solution prevented the use of higher concentrations of MU-Gal
than 0.5 mM. A solution of 87 mM MU-Gal in DMSO was
diluted to 2 mM in 50 mM phosphate-citrate buffer (pH 6)
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immediately before preparing the reactions. When crude enzyme
preparations from P. pastoris were used, a background signal likely
related to cleavage of MU-Gal by endogenous b-galactosidase was
present. This background signal could be removed by washing the
column eight times with 440 mL of 5 mM HCl after sample
application without desorbtion of the sialylated product and this
was therefore done routinely.
Optimisation of conditions for trans-sialylation
To determine the optimal conditions (pH, temperature, and
concentration of donor and acceptor), a quadratic central
composite design was used. MODDE Version 7.0.0.1 (Umetrics
AB, Umea˚, Sweden) was used as a tool to design the experimental
frame and to fit and analyse the data by multiple linear regression
analysis. The pH regimes 3, 4 and 5, incubation temperatures 20,
40 and 60uC, and concentrations of the acceptor lactose of 117,
234 and 351 mM were tested. Reactions were done using a fixed
concentration of cGMP-bound sialic acid of 8 mM in 15 mM
phosphate-citrate buffer with specified pH values, and using
15 mg/mL of Tr13 enzyme. Lactose and cGMP were solubilised in
buffer and preincubated at specific temperatures, before the
reactions were initiated by addition of enzyme. The biocatalysis
process was allowed to proceed for 20 min before the reaction was
stopped by heating for 10 min at 90uC. The concentration of
sialyllactose was determined by HPAEC as described below.
For a time study of the trans-sialylation reaction, Tr13 was
incubated as described above at pH 3 with 351 mM lactose,
8 mM cGMP-bound sialic acid and a reaction temperature of
25uC. The reaction was followed by sampling over a 100 min
period, and the concentration of sialyllactose was determined by
LC/MS as described below. Measurement at zero time was done
using heat-inactivated enzyme. Three replicates were made and
each data series fitted to a second-order polynomial function. For
each data series, the slope at time zero was used to calculate the
specific activity and the standard deviation.
Enzymatic production and purification of sialylated
glycans
The reactions were carried out in stirred glass bottles in reaction
volumes of 50 mL for melibiose and maltose, 88 mL for fucose,
100 mL for lactulose, and 250 mL for GOS and IMO. The
reaction was performed in 15 mM phosphate-citrate buffer (pH 3)
with 351 mM sialic acid acceptor (GOS, IMO, lactulose,
melibiose, maltose and fucose) and 8 mM cGMP-bound sialic
acid at 25uC using 15 mg/mL enzyme. Prior to the reaction, the
substrates were pre-incubated in the buffer. The reaction was
carried out for 20 minutes and then stopped by enzyme
inactivation by heating at 90uC for 10 minutes.
The reaction mixture was applied to a HiScale 50/20 (GE
Healthcare) anion exchange chromatography column packed with
Table 1. List of primers.
Name Sequence Description
Tr_fwd GCTCTCGAGAAGAGAGAGGCTGAAG XhoI, Tr 59
Tr_rev CGCTCTAGAAATGCTGCTGTACCAGC XbaI, Tr 39
Q123S_F CTATTGGACCTCTCACAGAGATGGATCTGACTGG Q123S
Q123S_R CATCTCTGTGAGAGGTCCAATAGTTCCTTGTCTTG Q123S
R125G_F GACCCAGCACGGAGATGGATCTGACTGGGAACC R125G
R125G_R CAGATCCATCTCCGTGCTGGGTCCAATAGTTCC R125G
G127A_F GCACAGAGATGCTTCTGACTGGGAACCATTGTTG G127A
G127A_R CCCAGTCAGAAGCATCTCTGTGCTGGGTCCAATAG G127A
E175Q_F ACTTACTAAGCAGTTCGTAGGTGGAGTAGGCG E175Q
E175Q_R CTCCACCTACGAACTGCTTAGTAAGTATGCCGTCGAACTC E175Q
V177L_F TAAGGAATTCTTGGGTGGAGTAGGCGCCG V177L
V177L_R CCTACTCCACCCAAGAATTCCTTAGTAAGTATGCCGTCG V177L
V180A_F CGTAGGTGGAGCTGGCGCCGCCATCGTG V180A
V180A_R TGGCGGCGCCAGCTCCACCTACGAATTCCTTAGTAAG V180A
G202K_F TGCTGACATGAAGGGAAGAGTATTTACAAAAATTATGTATTCC G202K
G202K_R ATACTCTTCCCTTCATGTCAGCAATTTGCACAG G202K
N250R_F AGTCGATTACAGAAGACGTCTGGTGTACGAATCC N250R
N250R_R CCAGACGTCTTCTGTAATCGACTCGGTTATTAATGATTAGC N250R
D363E_F GAGATTAATACTAATGAGGTTTATTCTCTTGTTTTTGTCCG D363E
D363E_R CAAGAGAATAAACCTCATTAGTATTAATCTCATGTAGGGAATATAATTTATC D363E
13MUT_F CCCTGTGCAAGTAACTAATAAGAAGAAGCAAGTATTTACAAAAATTATGTATTCCGAGG 13MUT
13MUT_R TTGTAAATACTTGCTTCTTCTTATTAGTTACTTGCACAGGGTATACCAAATTAC 13MUT
P98A_F GGTTGTCGATGCTACGGTCATAGTAAAGGGAAATAAGTTG P98A
P98A_R CTATGACCGTAGCATCGACAACCCTTGAAACTG P98A
Y249G_F CCGAGTCGATGGAAATAGACGTCTGGTGTACGAATC Y249G
Y249G_R GACGTCTATTTCCATCGACTCGGTTATTAATGATTAGC Y249G
Restriction sites are underlined and mutated nucleotides in bold.
doi:10.1371/journal.pone.0083902.t001
Trans-Sialidase for Efficient Glycan Sialylation
PLOS ONE | www.plosone.org 3 January 2014 | Volume 9 | Issue 1 | e83902
402 mL of Sepharose Q FF. The separation was done at ambient
temperature with an A¨KTA purifier 100 work station equipped
with a P-900 pump, UV-900 monitor, and Frac-950 fraction
collector, all controlled by UNICORN software (GE Healthcare).
The elution was monitored at 210 nm. Elution was performed at a
flow rate of 70 mL/min. Before injection, the column was
equilibrated with 5 column volumes (CV) of water. After injection,
the column was washed with 3 CV of water, followed by elution
with 3.5 CV of 40 mM ammonium formate and subsequently
with 2 CV of 400 mM ammonium formate for cleaning the
column. After elution, the column was regenerated with 3 CV of
water. Fractions of interest were collected automatically. The
products were lyophilized and ammonium formate was removed
by repeated solubilization and lyophilization. Product structures
were determined by LC/MS, as described below.
High-performance anion exchange chromatography
(HPAEC-PAD)
Quantification of sialyllactose was carried out by HPAEC-PAD
analysis using a Dionex BioLC system consisting of GS50 gradient
pumps, ED50 electrochemical detector, AS50 chromatography
compartment coupled to an AS50 autosampler (Dionex Corp.,
Sunnyvale, CA). Samples (10 mL) were injected on a CarboPacTM
PA1 (4 mm6250 mm) analytical column (Dionex Corp., Sunny-
vale, CA) at a flow rate of 1 mL/min. The elution program was
based on the method described in [20] except for the modifications
in the eluent system given below. The eluent system comprised of
deionised water (A), 0.5 M NaOH (B), 1 M NaOAc (C). For the
first 3 min an isocratic elution of 80: 20 (% A:B) was applied,
which was followed by a linear gradient from 80:20 (% A:B) to
60:20:20 (% A:B:C) from 3 to 27 min. Strongly retained anions
were removed from the column by isocratic elution at 40:20:40
(% A:B:C) from 27 to 31 min. Subsequently, the column was re-
equilibrated for 7 min with 80:20 (%A:B).
Capillary Liquid Chromatography/Mass spectrometry
For liquid chromatography/Mass spectrometry (LC/MS) anal-
ysis, an Agilent 1100 LC/Agilent 6340 ion trap MS system was
used. Oligosaccharides were separated using a Hypercarb porous
graphitic carbon (PGC) column (0.326150 mm, 5 mm, Thermo
scientific) at 30uC. Samples (0.5 mL) were loaded onto the column
in 10 mM ammonium bicarbonate. Gradient elution was achieved
using a binary solvent system consisting of (A) 10 mM ammonium
bicarbonate, adjusted to pH 8.5 with ammonium hydroxide, and
(B) 100% acetonitrile at a flow rate of 5 mL/min. The gradient was
initially at 98:2 (% A:B) for 5 min, followed by a linear increase to
42:58 (% A:B) at 33 min. This concentration of B was held for
3 min. Subsequently the eluent was returned to 98:2 (% A:B) at
40 min and the system was allowed to equilibrate for 10 min prior
to the next injection. All solvents used were of the highest HPLC
grade. The mass spectrometry was performed in negative ion
mode, and was scanned in the range m/z 150–2200 (2 microscans,
maximum accumulation time of 150 ms, an ion current count of
200,000) followed by data-dependent MS2 scans of the four most
abundant ions in each MS1 scan.
Bacterial growth assays on sialylated glycans
For testing growth of bacterial strains on sialylated glycans the
following strains were used: Bifidobacterium longum longum (Danisco
Global Culture Collection DGCC 232), Bifidobacterium longum
infantis (DGCC 233), Bifidobacterium longum infantis (DGCC 1497),
Bifidobacterium longum infantis (DGCC 2238), Lactobacillus acidophilus
(NCFM, ATCC 700396), Bifidobacterium longum (Bl-05, DGCC
9917), Bifidobacterium lactis (HN019, DGCC2013), and Clostridium
perfringens (ATCC 13124). Galactan from potato (Megazyme
International LTD, Bray, Co. Wicklow, Ireland) was used as an
established prebiotic standard control. The substrates were
dissolved in water at 10% (w/v) and sterilized by sterile filtration
(0.2 mm Minisart, Sartorius AG, Go¨ttingen, Germany) except for a
control substrate, galactan from potato (Megazyme International
LTD, Bray, Co. Wicklow, Ireland), that due to its high viscosity
was sterilised by UV-radiation for 30 seconds. The strains were
precultured in MRS2 medium (de Man, Rogosa and Sharpe
medium without glucose) with no additional sugars added for 24 h
at 37uC under anaerobic conditions before being diluted with fresh
MRS2 medium to 1% (v/v). Growth on test substrates was done
by adding 20 mL of 10% test substrates and 180 mL 1% cell
suspension in multiwell plates and growth was followed by
measurement of optical density at 600 nm (OD600) using BiolinkH
software (Labsystems) in a BioscreenH C system (Labsystems,
Helsinki, Finland) as described previously [21]. The growth in
MRS2 medium without addition of carbohydrates was used as
control. The experiments were done in three replicates for each
strain, and carbohydrate substrate and growth was determined as
the area under the growth curve. Data are given as mean values 6
standard error.
One-way analyses of variances (one-way ANOVA): 95%
confidence intervals were compared as Tukey-Kramer intervals
calculated from pooled standard deviations (Minitab Statistical
Software, Addison-Weseley, Reading, MA).
Results and Discussion
Rational design of the T. rangeli sialidase mutant Tr13
In order to identify mutations likely to affect enzyme activity, we
used two initial criteria: First, we considered only amino acids
within 14 A˚ of the sialic acid-binding site. Secondly, based on an
alignment between Tr6 and the efficient trans-sialidase TcTS, we
considered the chemical difference between the amino acids,
assuming that larger chemical differences, correlating with lower
probability of substitution by random evolution, would be the most
likely candidates for conferring increased trans-sialidase activity
and/or reduce unwanted hydrolysis. We also inspected the impact
of changes in surface exposure, hydrogen bonding, and the
distance from the acceptor binding site. A sequence alignment
with amino acids within 14 A˚ of the sialic acid-binding site and
sites selected for mutagenesis are shown in Figure 1.
Among significant differences, the motif composed of amino
acids 197–203 is IADMGGR in TrSA and Tr6, but is substituted
to VTNKKKQ in TcTS. These substitutions cause a change in
net charge of +3, and the MGGR R KKKQ sequence of
substitution is highly unlikely to occur randomly (24 in total from
a BLOSUM62 matrix [22]). The substitution of two Gly residues
to Lys could alter the rigidity of the loop. This changed rigidity
might affect exclusion of water from the active site which could in
turn explain the reduced hydrolytic activity observed in TcTS. To
investigate this hypothesis, we compared the loops in structures of
TcTS and TrSA with and without a ligand bound (Figure 2). A
comparison of the loops shows little difference in the backbone
position between the two enzymes and neither of them appeared
to change conformation upon ligand binding. This indicates that
the chemical properties of the side chains, rather than the size and
backbone dynamics of the loops, are likely to determine differences
in catalytic activity. Consequently, an alternative explanation for
the role of the VTNKKKQ motif was sought in the introduction
of a +3 charge difference between the two loops. This charge
difference is also seen in the less similar trans-sialidase from
Trans-Sialidase for Efficient Glycan Sialylation
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T. congolense (ARNKANR, charge +3), but not in that of T. brucei
(ARNEDNA, charge –1). We hypothesised that the charge
difference and/or the substantial change towards hydrogen-bond
donors could affect the affinity for lactose or reverse the water
network in the substrate-binding cleft (or reduce water affinity, i.e.
increase Km for hydrolysis to favour competitive binding of
lactose), all to the effect of reducing hydrolysis. Energetically, the
free energy cost of aligning water molecules in the cleft
(rearrangement free energy of ,6.3 kJ/mol [23]) should be lower
than for fully excluding them (free energy of hydration of water
into water with an upper cost of ,35 kJ/mol [24]).
A homology model of mutant Tr13 based on Tr6 with the
additional seven mutations of the VTNKKKQ motif is shown in
Figure 3. The mutations are relatively far, ,14 A˚, from the
acceptor binding site and therefore unlikely to affect acceptor
binding directly. Water structure is from recent work known to be
a combination of symmetric, directed tetrahedral structure and
momentaneous asymmetry from breaking of hydrogen bonds [25].
The substantial increase of hydrogen bond donation from the loop
side suggests that a tetrahedral water network of the symmetric
type will be more likely to be inverted. This would change the
electrostatic field in the cleft and potentially disrupt or even reverse
the water network in the active site. Hydrolysis requires a water
network aligned with oxygen lonepairs towards the sialic acid,
whereas a strong positive charge and hydrogen-donor tendency at
the edge of the binding cleft, as seen in the native trans-sialidase
would work towards a partial reversal of such a network, turning
oxygen lone pairs towards the field of the lysines and correspond-
ingly impairing the nucleophilicity of the water network in the
cleft. Such a disruption of the water network could be the
explanation for TcTS’s exquisite quenching of hydrolysis, not
achieved by previous T. rangeli sialidase mutants [4].
In addition to the VTNKKKQ motif probed by Tr13, we also
investigated several single-site mutations from Tr6, to understand
the properties of previously described mutants in more detail. Two
such mutations were reverting mutations of the parent, P98A and
Y249G, while V180A was the mutant previously reported to at
least partially reduce hydrolase activity [4]. As further candidates
for improving trans-sialidase activity, several new single mutations
were also made from Tr6: R125G, E175Q, G202K, N250R,
Figure 1. Sequence alignment of sialidase catalytic domain from Tr6 and related trans-sialidases. Tr6 and trans-sialidases from T. cruzi
(Uniprot ID Q26966), T. congolense (Uniprot ID G0WJG3) and T. brucei (Uniprot ID Q57XJ2) were aligned using ClustalW. Amino acids within 14 A˚ of
sialic acid binding site are shown in bold. The seven amino acid motif is indicated with filled circles, reverting mutations are indicated with a triangle
while other mutated sites are indicated with asterisks.
doi:10.1371/journal.pone.0083902.g001
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Q123R, G127A, I177L, and D363E. These mutations were
notable either by their positions close to the binding cleft and/or
by conferring a chemical difference.
Sialidase mutant Tr13 displays increased trans-sialylation
activity
To assess the performance of the mutants, we produced them in
P. pastoris shake flask cultures and tested their trans-sialidase
activity using a fluorescence-based assay using cGMP as sialic acid
donor and methylumbelliferyl-b-D-galactopyranoside (MU-Gal)
as acceptor (Figure S2). The enzyme amounts obtained were too
low to allow a detailed characterization of the mutants. Since the
detected maximum product yield will be a measure of both the
trans-sialidase activity (product formation) and the hydrolase
activity (donor and product degradation) of the enzyme, it was
considered a relevant assay for an initial screen of the mutants.
Figure 2. Comparison of the loop motif in TcTS and TrSA. Structures of TcTS (PDB 1MS1; grey and 1MS3; light red) and TrSA (PDB 1N1T; blue
and 1N1S; green), with and without the sialic acid analogue DANA bound respectively, were compared. The loop motif constituted by amino acids
196–202/197–203 and DANA bound in active site between catalytic residues Glu-230/231, Tyr-342/343 and Asp59/60 in TcTS and TrSA respectively
are displayed.
doi:10.1371/journal.pone.0083902.g002
Figure 3. Homology model of Tr13. Close-up of active site with sialyllactose docked (blue). Acceptor binding site residues Tyr-120 and Trp-313
and catalytic nucleophile Tyr-343 side chains are shown in grey. The seven introduced amino acids are shown in yellow.
doi:10.1371/journal.pone.0083902.g003
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Although all the mutants were active, only Tr13 and Tr6 D363E
performed at a level comparable to Tr6 while all other mutants
displayed a decreased trans-sialidase activity. These two mutants
were therefore selected for further analysis, since the primary
objective of this work was to generate mutants displaying
improved trans-sialidase activity. It is worth noting that the single
mutation G202K, which is part of the VTNKKKQ motif,
reduced trans-sialidase activity. This indicates a co-operation effect
of the amino acids of the motif and not an effect additively derived
from the single-site mutations. For the reverting mutations P98A
and Y249G it could be concluded that they improve but are not
essential for trans-sialidase activity.
For further evaluation we produced the parent enzyme Tr6 and
the two mutants Tr13 and Tr6 D363E in a 5 L fermentor. This
allowed us to evaluate both hydrolase and trans-sialidase activity
(Figure 4). Hydrolase activity was tested on the artificial substrate
pNP-Neu5Ac as well as on the natural substrates 39-sialyllactose,
69-sialyllactose, and cGMP. None of the enzymes exhibited
detectable activity on 69-sialyllactose (data not shown) in turn
indicating that the a-2,6-linked sialic acid in cGMP was not used
as a sialyl donor when cGMP was employed as donor substrate for
the T. rangeli mutants. The a-2,6-linked sialic acid constitutes
about 50% of total sialic acid content in cGMP [26]. While both
Tr13 and Tr6 D363E had a decreased activity on pNP-Neu5Ac,
only Tr13 had a lower hydrolase activity on 39-sialyllactose and
cGMP (Figure 4A).
In the trans-sialidase activity assay, the initial reaction rate
represents the trans-sialidase reaction rate, while maximum
product formation is a measure of both trans-sialidase activity
(product formation) and hydrolase activity (product degradation).
Thus, Tr6 and Tr13 appeared to have similar trans-sialidase
activities (as measured by their initial reaction rates), while Tr6
D363E had a slightly lower activity, but under the applied reaction
conditions Tr13 accomplished twice the maximal yield (Figure 4B),
underscoring the importance of the VTNKKKQ motif for total
yields due to reduced hydrolysis activity on the product.
The improved maximal yield obtained for Tr13 catalysis
suggests that the VTNKKKQ motif does not affect the acceptor
binding affinity, but rather uniquely reduces the hydrolytic activity
(water kcat and/or Km), probably by impairing water nucleophi-
licity for attack on sialic acid (partial reversal of the water network)
and/or by reducing water’s retention time in the active site in
competition with the acceptor. The effect may be acceptor-
dependent, as the total extent of hydrolysis not only depends on
the impaired water network, but also the Km of the acceptor during
trans-sialylation, which affects acceptor vs. water retention time
and thus, the competition between hydrolysis and trans-sialylation.
Of the three lysines introduced in Tr13, K200 and K201 are
partly shielded from the active site (Figure 3) while K202 points
towards the center of the site. Changing only K202 led to a
reduced activity compared to the parent. The exact mechanism by
which the mutations exert their effect remains unclear and
certainly these mutations do not completely account for the
exceptionally low hydrolase activity and the higher affinity for
lactose in TcTS compared to Tr6. Tr13 however, represents a
major step forward by providing the first-ever design of a markedly
hydrolysis-impaired sialidase mutant. Within protein engineering
at large, viable mutants with improved properties that deviate so
substantially from a wild type (by 13 site changes including a 7-
amino acid loop structure with a +3 charge difference) are
unusual.
Optimization of reaction conditions for Tr13
Statistically designed experiments were performed to determine
reaction conditions that favour the trans-sialidase activity of Tr13.
The influence of the following factors was investigated: temper-
ature (20–60uC), pH (pH 3–5) and concentration of a standard
acceptor for this reaction, lactose (117–351 mM), while using a
fixed concentration of cGMP (8 mM). Reactions were allowed to
proceed for 20 min, and after terminating the reactions, the
concentration of 39-sialyllactose was determined by HPAEC. No
product formation was observed in controls with heat-inactivated
enzyme. The highest product yield was obtained at 351 mM
lactose (highest tested), pH 3 (lowest tested) and at 20uC (lowest
tested) (data not shown). A time study was performed at these
conditions and the specific trans-sialidase activity of the enzyme
was determined from this study shown in Figure 5. The specific
trans-sialidase activity, measured as number of sialyl-moieties
transferred, of Tr13 was 4.4 +/20.7 nmol*min21 per mg of
enzyme on cGMP. It was apparent that for a higher product yield,
the reaction time could be successfully extended from 20 to 100
minutes with no detectable product degradation, since no free
sialic acid was detected by LC/MS. Although the maximum yield
was not determined in the study, it could be concluded that at least
Figure 4. Enzyme activity of Tr6 and selected mutants Tr13 and Tr6 D363E. A) Hydrolase activity on substrates pNP-Neu5Ac, 39-sialyllactose,
and cGMP. B) Trans-sialidase activity using cGMP as sialic acid donor and MU-gal as acceptor.
doi:10.1371/journal.pone.0083902.g004
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,2.5 mM 39-sialyllactose could be produced. In cGMP, a-2, 3-
and a-2,6-bound sialic acid is in a ratio of about 1:1 [26], and
hence only 4 of the 8 mM cGMP-bound sialic acid was
theoretically accessible giving a yield of about 63%.
That the highest product yield was obtained at very low pH is
surprising, since pHopt for TcTS (using N-acetyllactosamine as
acceptor) is pH 7 [27]. The introduction of charged residues in the
vicinity of the catalytic residues might modulate the pH optimum
but unlikely by such magnitude. A temperature optimum of 13uC
has been reported for TcTS at low acceptor concentration
(7.2 mM) due to increased affinity for the acceptor at low
temperature while increasing acceptor concentration increased
Topt [28]. In our case, however, a very high acceptor concentra-
tion was used, indicating a different mechanism for the optimum
at low temperature.
Sialylation of various prebiotic glycans revealed
promiscuous acceptor substrate specificity of Tr13
We also examined the possibility of using Tr13 for synthesis of
chimeric molecules, probing the possibility of combining the
prebiotic effect with sialic acid as found in many HMO molecules
to assess potential, enhanced beneficial properties. To this end, we
sialylated the well-documented prebiotics GOS, IMO, and
lactulose as well as three other compounds, melibiose, maltose,
and fucose. This also provided a possibility to probe the acceptor
substrate specificity of this enzyme. For TcTS it is generally
accepted that terminal galactose moieties function as acceptor with
lactose being a better acceptor than melibiose and galactose,
glucose being a poor one [29]. Here we tested terminal galactose,
terminal glucose, and glucose and fucose monomers as acceptor
substrates for Tr13.
The sialylated oligosaccharides were enzymatically produced in
phosphate-citrate buffer at pH 3 at ambient temperature.
351 mM sialic acid acceptor and 8 mM cGMP-bound sialic acid
was used. After incubation for 20 minutes, the enzyme was heat-
inactivated and the sialylated products were purified by anion
exchange chromatography (Figure 6). In the unbound fractions,
there was always neutral, unreacted acceptor, which was eluted
with water. Applying 40 mM ammonium formate led to elution of
negatively charged compounds, i.e. sialylated products and
afterwards free sialic acid. According to LC/MS analysis, the
sialylated compounds were completely separated from sialic acid
as well as from the acceptor used in the reaction. The highest
yields were achieved when fucose (1.5 mM) and lactulose
(1.9 mM) were used as the sialic acid acceptors. Due to the
relatively low yield compared to the concentration of acceptor
substrates, it was relevant to assure that the substrates did not
contain sialylated compounds. Analysis of the lactulose and
melibiose preparations by LC/MS identified no contamination
with sialylated compounds or sialic acid. The yields of sialylation
products of GOS and IMO were lower. GOS and IMO
preparations were a mixture of oligosaccharides of different chain
length. The yields for each of the different chain lengths might
have differed from the average since sialylation of smaller species
appear to be favoured, at least for trans-sialylation with bacterial
sialidases [30]. The composition of products of sialylation of GOS
and IMO was complex (Table 2): Four and five different sialylated
compounds, respectively, were obtained. In the case of GOS, the
product of the lowest molecular weight was sialyllactose (m/z of
632), whereas incubation of IMO with cGMP led to production
also of sialylated glucose (m/z of 470), since the starting material
was abundant in that monomer.
Of the compounds produced, sialyllactulose was produced in
the highest molar yield. The presence of galactose and the 1,4-b
bond between galactose and fructose may make lactulose more
accessible for Tr13, since for the similar-size acceptors melibiose
(1,6-a-bound galactose) and maltose (1,4-a-bound glucose), yields
were less than 60% of those obtained with lactulose. It is well
established that glycans containing terminal galactose can be
sialylated by TcTS, but the fact that Tr13 could also sialylate
terminal glucose and even glucose and fucose monomers was
surprising and indicated a high level of acceptor promiscuity. To
our knowledge, this is the first report of such broad acceptor
substrate specificity, and it can potentially be a valuable asset for
enzymatic synthesis of a broad range of sialylated glycans using the
Tr13 enzyme as catalyst.
Potential prebiotic effect of various sialylated glycans
The end-goal for this ongoing research effort is the enzymatic
synthesis of novel functional food ingredients. As an initial
assessment of potential prebiotic properties of the sialylated
glycans, their growth promoting activity on selected bacterial
pure cultures comprising three strains of B. longum subs. infantis,
two B. longum subsp. longum, one B. lactis, one L. acidophilus and one
pathogenic strain of C. perfringens was evaluated. This was done
using a Bioscreen microtiter system, and the growth performance
was expressed as area under the growth curve [21]. To assess the
impact of sialylation it would have been relevant to compare with
growth on the unsialylated acceptor molecules, but since the
distribution of sialylated molecules of different chain length in case
of GOS and IMO was not quantified, we decided to use galactan
from potato as a control due to its confirmed prebiotic properties
[31].
The data presented in Table 3 revealed that within the group of
probiotic strains, sialylated melibiose and maltose did not appear
to promote growth. For B. infantis 233, B. infantis 1497, and B.
longum 232, growth was promoted by different sialylated
compounds while sialylated fucose promoted growth for all three.
In the case of B. infantis 2238, B. lactis, L. acidophilus, and B. longum
9917, none of the sialylated compounds promoted growth, while
L. acidophilus grew well on the prebiotic control substrate galactan.
C. perfringens grew significantly better than all the probiotic strains
on the sialylated compounds, except on sialylmelibiose where
growth was not tested due to only a limited amount of material
being available.
It was assumed that a prerequisite for utilising the sialylated
compounds would be the presence of a sialidase, as well as the
ability to degrade the prebiotic backbone. All the B. longum subsp.
Figure 5. Time study of trans-sialylation catalysed by Tr13.
Accumulation of 39-sialyllactose over time in 25uC, pH 3, 351 mM
lactose and 8 mM cGMP-bound sialic acid.
doi:10.1371/journal.pone.0083902.g005
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infantis strains contained a sialidase (data not shown) as does C.
perfringens, which contains the necessary enzymes for metabolising
sialic acid [32]. Although variations in growth were found on
different substrates, even within species, it was evident that the
majority of the bacteria tested, including C. perfringens, to some
extent were able to grow on the sialylated compounds. Recently,
three fucosylated HMOs were shown to stimulate bifidobacteria,
while E. coli and C. perfringens were unable to utilise the HMOs
[33]. More interestingly, the organic acid fermentation product
inhibited their growth, raising the possibility that this might also
take place in a mixed culture with the molecules synthesised in this
study. A mixed culture experiment taking into account bacterial
interactions would be required to assess this. Furthermore, the
potential functionality of these compounds as decoy molecules and
Figure 6. Anion exchange separation profiles for sialylated glycans. Sialylated glycans separated from sialic acid and unused acceptor
separated by Sepharose Q and detected at 210 nm.
doi:10.1371/journal.pone.0083902.g006
Table 2. Products of sialylation of various glycans analysed by LC/MS.
acceptor m/z product Product conc. Product yield
[M-H]2 [g/L] [wprod/waccep] [mM]
GOS 632 SA-a-Gal-1,4-b-Glc 1.0 0.44% ND
794 SA-a-Gal-1,4-b-Gal-1,4-b-Glc
956 SA-a-Gal-1,4-b-Gal-1,4-b-Gal-1,4-b-Glc
1118 SA-a-Gal-1,4-b-Gal-1,4-b-Gal-1,4-b-Gal-1,4-b-Glc
Fucose 454; SA-a-Fuc 0.66 1.17% 1.46
Melibiose 632 SA-a-Gal-1,6-a-Glc 0.62 0.52% 0.98
Lactulose 632 SA-a-Gal-1,4-b-Fru 1.2 0.97% 1.84
Maltose 632 SA-a-Glc-1,4-a-Glc 0.66 0.55% 1.04
IMO 470 SA-a-Glc 0.72 0.60% ND
632 SA-a-Glc-a-Glc
794 SA-a-Glc-a-Glc-a-Glc
956 SA-a-Glc-a-Glc-a-Glc-a-Glc
1118 SA-a-Glc-a-Glc-a-Glc-a-Glc-a-Glc
Yields are given as product concentration and as% (w/w) of product produced from acceptor used. ND; the molar concentration of sialylated GOS and IMO could not be
calculated since the distribution of different chain lengths was not determined. Abbreviations: SA, sialic acid; Gal, galactose; Glc, glucose; Fuc, fucose; Fru, fructose.
doi:10.1371/journal.pone.0083902.t002
Trans-Sialidase for Efficient Glycan Sialylation
PLOS ONE | www.plosone.org 9 January 2014 | Volume 9 | Issue 1 | e83902
in modulation of the immune system will need to be addressed in
future work.
Concluding Remarks
Previous work by Paris and co-workers [4] identified important
residues in the acceptor binding site and in the sialic acid-binding
pocket that conferred trans-sialidase activity to the strict sialidase
of T. rangeli. However, these mutants all retained a much higher (at
least 100-fold) hydrolase activity compared to the native trans-
sialidase of T. cruzi, indicating that a major determinant of
impaired hydrolysis in the evolution of trans-sialidase was missing.
In this study, we have shown that a major chemical and
structural difference between the native trans-sialidase TcTS and
the homologous sialidase TrSA lies in the presence of a +3 charged
VTNKKKQ motif on the edge of the acceptor binding cleft, and
that this motif effectively reduces hydrolysis to promote trans-
sialidase activity. The most likely function of this motif is to
effectively disrupt (perhaps even reverse) the water binding
network, which must be aligned with the oxygen lone pairs
towards sialic acid in order to accomplish hydrolysis. Since the
motif is not conserved among characterized trans-sialidases its
beneficial effect might be context-dependent. Further structural
and enzymatic studies will certainly be needed to assess the validity
and generality of the proposed mechanisms.
A mutant, Tr13, was constructed from the parent Tr6 mutant,
with this identified motif incorporated and it was shown to display
a 4-fold lower hydrolase activity on 39-sialyllactose, while trans-
sialidase activity was essentially unaffected. As a result, a net
doubling of the yield of sialylated product was obtained using this
particular mutant Tr13, which also produced a better yield than a
series of controlling single-site mutants. The mutant is therefore
the first in a new class of envisioned mutants capable of reducing
hydrolysis in competition with trans-sialidase activity by disruption
of the water network of the acceptor-binding site and active site.
Tr13 is also remarkable by being chemically substantially different
from its wild type, with 13 sites mutated and a charge difference of
+3.
Furthermore, the native TcTS is generally believed to use only
terminal galactose as acceptor substrates [29], but Tr13 possessed
an unusually broad acceptor-substrate specificity, accommodating
terminal galactose but also terminal glucose and even monomers
of glucose and fucose. This, together with the substantially reduced
hydrolysis, should make Tr13 and its downstream mutants useful
for enzymatic sialylation of a broad range of glycans in the pursuit
of novel, functional food ingredients. To justify this approach, a
number of established and potential prebiotics, including GOS,
IMO, and lactulose, were sialylated in reasonable yields. An initial
examination of prebiotic potential demonstrated growth of
Bifidobacteria, although not selectively. Using Tr13 under optimal
conditions should further allow a synthesis-scale of these novel
molecules enabling further functionality tests including their
prebiotic effect in mixed culture, and their potential as anti-
adhesive antimicrobial and modulator of the immune system.
Supporting Information
Figure S1 The gene sequence and primary structure of
Tr6. Restriction sites used for vector construction are underlined.
pPICZaC (Invitrogen)-encoded N-terminus containing a-factor
signal sequence and Kex2 and Ste3 protease recognition sequence
(amino acids 1–89) and C-terminus containing c-myc and 6xHis-tag
(amino acids 730–752) in grey. Tr6 gene product (amino acids 90–
729) in bold.
(PDF)
Figure S2 Trans-sialidase activity of Tr6 and derived
mutants. Trans-sialidase activity measured using cGMP as sialic
acid donor and methylumbellferyl-pyrogalactoside as acceptor.
Product formation, for each of the mutant variants shown against
that of the parent Tr6, is shown in arbitrary units. Differences in
initial reaction rate might in part relate to differences in enzyme
amount used.
(PDF)
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Table 3. Bacterial growth on sialylated glycans.
Bacterial strain Area under the growth curve [OD600 x min]
MRS- S-GOS S-fucose S-melibiose S-lactulose S-maltose S-IMO galactan
B. infantis 233 30614 13265 7166 1466 109620 3064 95623 5567
B. infantis 2238 294668 274618 285615 30262 269620 158624 26966 26467
B. infantis 1497 31610 42613 14962 ND 3462 ND 4561 4069
B. longum 232 79620 16269 192620 104617 134619 122631 107619 42613
B. lactis 139670 176618 192627 ND 122618 10268 175613 143615
L. acidophilus 180628 15964 188618 19264 12862 193612 217619 371610
B. longum 9917 106630 7165 114615 7068 34614 10166 10369 93644
C. perfringens 455632 722652 811648 ND 541617 844699 1098661 447646
Area under the growth curve for growth of probiotic strains and pathogenic Clostridium perfringens on sialylated glycans; MRS- represents growth in the medium with
no carbohydrate added; galactan, an established prebiotic, was used as a positive control; growth responses for the substrates are shown for a substrate concentration
of 10 g/L for all bacterial strains. Data are given as average values of 3 replicates and shown 6 s.d. The growth of B. longum infantis 1497, B. lactis and C. perfringens was
not tested on sialylmelibiose, as well as, growth of B. longum infantis 1497 on sialylmaltose (ND).
doi:10.1371/journal.pone.0083902.t003
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